Ligand Reports Fourth Quarter and Full Year 2025 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/24/2026

1. META
2. P
3. ORCL
4. OKTA
5. SPY
6. MGM
7. NVDA
8. MCD
9. GDDY
10. COST

Go back to Ligand Reports Fourth Quarter and Full Year 2025 Financial Results
LIGAND PHARMA (NASDAQ: LGND) Delayed: 299.04 +0.63 (0.21%)
Previous Close $298.41    52 Week High $139.79 
Open $296.95    52 Week Low $82.07 
Day High $303.41    P/E 695.44 
Day Low $296.37    EPS $0.43 
Volume 209,419